REXULTI is indicated for: Adjunctive treatment of major depressive disorder (MDD) in adult.
Treatment of schizophrenia in adult and pediatric patients ages 13 years and older.
Treatment of agitation associated with dementia due to Alzheimer's disease.
Limitations of Use: REXULTI is not indicated as an as needed ("prn") treatment for agitation associated with dementia due to Alzheimer's disease.
Other Services
Country
Account